Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Non Operating Income (2020 - 2025)

Treace Medical Concepts' Non Operating Income history spans 6 years, with the latest figure at -$3.5 million for Q4 2025.

  • For Q4 2025, Non Operating Income fell 1069.02% year-over-year to -$3.5 million; the TTM value through Dec 2025 reached -$4.8 million, down 8714.55%, while the annual FY2025 figure was -$4.8 million, 8714.55% down from the prior year.
  • Non Operating Income reached -$3.5 million in Q4 2025 per TMCI's latest filing, down from -$612000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $781000.0 in Q2 2023 to a low of -$5.3 million in Q2 2022.
  • Average Non Operating Income over 5 years is -$750750.0, with a median of -$518000.0 recorded in 2025.
  • Peak YoY movement for Non Operating Income: skyrocketed 154.75% in 2023, then tumbled 1069.02% in 2025.
  • A 5-year view of Non Operating Income shows it stood at -$1.0 million in 2021, then increased by 10.47% to -$915000.0 in 2022, then skyrocketed by 154.75% to $501000.0 in 2023, then crashed by 159.28% to -$297000.0 in 2024, then crashed by 1069.02% to -$3.5 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Non Operating Income are -$3.5 million (Q4 2025), -$612000.0 (Q3 2025), and -$424000.0 (Q2 2025).